Inventor
LIU LIQIN
CN16 patents
⚠️ This page may combine multiple inventors who share the name “LIU LIQIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MACROGENICS INC
10 patentsUS10647768B2May 12, 2020
Multi-chain polypeptide-containing tri-specific binding molecules
MACROGENICS INC19 citations92
US9908938B2Mar 6, 2018
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
MACROGENICS INC6 citations82
US10633443B2Apr 28, 2020
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof
MACROGENICS INC3 citations73
US11459394B2Oct 4, 2022
Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof
MACROGENICS INC4 citations72
US11820818B2Nov 21, 2023
Multi-chain polypeptide-containing tri-specific binding molecules
MACROGENICS INC1 citations71
US11421031B2Aug 23, 2022
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
MACROGENICS INC2 citations71
US11942149B2Mar 26, 2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof
MACROGENICS INC1 citations62
US11639386B2May 2, 2023
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof
MACROGENICS INC1 citations62
US10730947B2Aug 4, 2020
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
MACROGENICS INC1 citations61
US11795226B2Oct 24, 2023
Bispecific CD16-binding molecules and their use in the treatment of disease
MACROGENICS INC0 citations46